ICI-118,551

ICI-118,551
Nazivi
	IUPAC naziv 3-(izopropilamino)-1-[(7-metil-4-indanil)oksi]butan-2-ol
Identifikacija
CAS broj	72795-19-8 ;
3D model (Jmol)	interaktivna slika;
MeSH	ICI 118551
PubChem C ID	3682;
	SMILES CC1=C2CCCC2=C(C=C1)OCC(C(C)NC(C)C)O; ; ; ; ; ;
Svojstva
Hemijska formula	C17H27NO2
Molarna masa	277,402 g/mol
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	verifikuj (šta je ?)
	Reference infokutije

ICI-118,551 je selektivni antagonist beta-2 (β₂) adrenergičkog receptora.^[3]^[4] ICI se vezuje za β₂ receptor sa više od sto puta većim afinitetom nego za β₁ ili β₃ receptor.^[5]^[6] Kompanija Imperijalne hemijske industrije je razvila ovo jedinjenje.

Reference

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Hillman KL, Doze VA, Porter JE (2005). „Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus”. The Journal of Pharmacology and Experimental Therapeutics. 314 (2): 561—7. PMID 15908513. doi:10.1124/jpet.105.084947.
^ Summerhill S, Stroud T, Nagendra R, Perros-Huguet C, Trevethick M (2008). „A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors”. Journal of Pharmacological and Toxicological Methods. 58 (3): 189—97. PMID 18652905. doi:10.1016/j.vascn.2008.06.003.
^ Mauriège P, De Pergola G, Berlan M, Lafontan M (1988). „Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta-1 antagonists”. Journal of Lipid Research. 29 (5): 587—601. PMID 2900871.
^ Emorine, L. J.; Marullo, S.; Briend-Sutren MM; et al. (1989). „Molecular characterization of the human beta 3-adrenergic receptor”. Science. 245 (4922): 1118—21. PMID 2570461. doi:10.1126/science.2570461.

Spoljašnje veze

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

[2] Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.

[pmid15908513-3] Hillman KL, Doze VA, Porter JE (2005). „Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus”. The Journal of Pharmacology and Experimental Therapeutics. 314 (2): 561—7. PMID 15908513. doi:10.1124/jpet.105.084947.

[pmid18652905-4] Summerhill S, Stroud T, Nagendra R, Perros-Huguet C, Trevethick M (2008). „A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors”. Journal of Pharmacological and Toxicological Methods. 58 (3): 189—97. PMID 18652905. doi:10.1016/j.vascn.2008.06.003.

[pmid2900871-5] Mauriège P, De Pergola G, Berlan M, Lafontan M (1988). „Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta-1 antagonists”. Journal of Lipid Research. 29 (5): 587—601. PMID 2900871.

[pmid2570461-6] Emorine, L. J.; Marullo, S.; Briend-Sutren MM; et al. (1989). „Molecular characterization of the human beta 3-adrenergic receptor”. Science. 245 (4922): 1118—21. PMID 2570461. doi:10.1126/science.2570461.

[1]

[2]

[3]

[4]

[5]

[6]